-
Je něco špatně v tomto záznamu ?
Parasitic fungus Claviceps as a source for biotechnological production of ergot alkaloids
H. Hulvová, P. Galuszka, J. Frébortová, I. Frébort,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- Claviceps genetika metabolismus MeSH
- enzymy metabolismus MeSH
- fermentace MeSH
- genetické inženýrství metody MeSH
- molekulární struktura MeSH
- námelové alkaloidy biosyntéza chemie genetika farmakologie MeSH
- průmyslová mikrobiologie metody MeSH
- žito mikrobiologie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Ergot alkaloids produced by the fungus Claviceps parasitizing on cereals, include three major groups: clavine alkaloids, d-lysergic acid and its derivatives and ergopeptines. These alkaloids are important substances for the pharmatech industry, where they are used for production of anti-migraine drugs, uterotonics, prolactin inhibitors, anti-Parkinson agents, etc. Production of ergot alkaloids is based either on traditional field cultivation of ergot-infected rye or on submerged cultures of the fungus in industrial fermentation plants. In 2010, the total production of these alkaloids in the world was about 20,000 kg, of which field cultivation contributed about 50%. This review covers the recent advances in understanding of the genetics and regulation of biosynthesis of ergot alkaloids, focusing on possible applications of the new knowledge to improve the production yield.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031942
- 003
- CZ-PrNML
- 005
- 20131002114426.0
- 007
- ta
- 008
- 131002s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biotechadv.2012.01.005 $2 doi
- 035 __
- $a (PubMed)22261014
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hulvová, Helena $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic.
- 245 10
- $a Parasitic fungus Claviceps as a source for biotechnological production of ergot alkaloids / $c H. Hulvová, P. Galuszka, J. Frébortová, I. Frébort,
- 520 9_
- $a Ergot alkaloids produced by the fungus Claviceps parasitizing on cereals, include three major groups: clavine alkaloids, d-lysergic acid and its derivatives and ergopeptines. These alkaloids are important substances for the pharmatech industry, where they are used for production of anti-migraine drugs, uterotonics, prolactin inhibitors, anti-Parkinson agents, etc. Production of ergot alkaloids is based either on traditional field cultivation of ergot-infected rye or on submerged cultures of the fungus in industrial fermentation plants. In 2010, the total production of these alkaloids in the world was about 20,000 kg, of which field cultivation contributed about 50%. This review covers the recent advances in understanding of the genetics and regulation of biosynthesis of ergot alkaloids, focusing on possible applications of the new knowledge to improve the production yield.
- 650 _2
- $a Claviceps $x genetika $x metabolismus $7 D002967
- 650 _2
- $a enzymy $x metabolismus $7 D004798
- 650 _2
- $a námelové alkaloidy $x biosyntéza $x chemie $x genetika $x farmakologie $7 D004876
- 650 _2
- $a fermentace $7 D005285
- 650 _2
- $a genetické inženýrství $x metody $7 D005818
- 650 _2
- $a průmyslová mikrobiologie $x metody $7 D007218
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a žito $x mikrobiologie $7 D012434
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Galuszka, Petr $u -
- 700 1_
- $a Frébortová, Jitka $u -
- 700 1_
- $a Frébort, Ivo $u -
- 773 0_
- $w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 31, č. 1 (2012), s. 79-89
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22261014 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131002114943 $b ABA008
- 999 __
- $a ok $b bmc $g 996029 $s 830387
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 31 $c 1 $d 79-89 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
- LZP __
- $a Pubmed-20131002